The new advancements in the treatment of osteoporosis, with the latest parathyroid hormone–related protein analogue, abaloparatide, or in congenital adrenal hyperplasia with the new long-lasting hydrocortisone formulation, are notable examples. This evidence concerns the gene PTH and osteoporosis.